Arcade Therapeutics is a New York-based startup revolutionizing mental health treatment through therapeutic gaming. Committed to evidence-backed solutions, the company utilizes cutting-edge cognitive neuroscience to develop engaging games aimed at addressing various mental illnesses. Recognized for its innovative approach, Arcade won the 2022 Rising Star Award from the Digital Health Hub Foundation and was named a Top 10 Startup to Watch in 2023 by Digital Health NY. The company is dedicated to obtaining FDA approval for its pipeline of therapeutic games targeting conditions such as social anxiety disorder, generalized anxiety disorder, major depressive disorder, alcohol use disorder, as well as mental health conditions related to pregnancy and multiple sclerosis. With its Arcade Connect platform, the company aims to seamlessly integrate these treatments into healthcare workflows, facilitating distribution from provider to patient and enabling reimbursement via digital formularies. Established in 2019, Arcade Therapeutics recently secured a $1.50M Seed Round investment on 16 February 2024, marking a significant milestone in its journey toward transforming mental health care.
No recent news or press coverage available for Arcade Therapeutics.